ArticleComputational and structural biotechnology journal2025
PCLDA: An interpretable cell annotation tool for single-cell RNA-sequencing data based on simple statistical methods.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- scUmaper: An automated framework for doublet removal and cell-type annotation in single-cell transcriptomics.iScience · 2026Article
- ArchetypeShift: An R Package Integrating KEGG-Informed Pathway Analysis and IPA-Derived Functional Predictions for Validation of Single-Cell Archetypes.Bioinformatics and biology insights · 2026Article
- FUNCellA: A Tool for Single-Sample Enrichment Analysis and Relative Pathway Activity Estimation in Single-Cell RNA Sequencing Data.Computational and structural biotechnology journal · 2026Article
- scANMF: Prior Knowledge and Graph-Regularized NMF for Accurate Cell Type Annotation in scRNA-seq.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity, yet accurate and consistent cell-type annotation remains a crucial challenge. Numerous automated tools exist, but their complex modeling assumptions can hinder reliability across varied datasets and protocols. We propose PCLDA, a pipeline composed of three modules: t-test-based gene screening, principal component analysis (PCA) and linear discriminant analysis (LDA), all built on simple statistical methods. An ablation study shows that each module in PCLDA contributes significantly to performance and robustness, with two novel enhancements in the second module yielding substantial gains. Despite these additions, the model retains its original assumptions, computational efficiency, and interpretability. Benchmarking against nine state-of-the-art methods across 22 public scRNA-seq datasets and 35 distinct evaluation scenarios, PCLDA consistently achieves top-tier accuracy under both intra-dataset (cross-validation) and inter-dataset (cross-platform) conditions. Notably, when reference and query data are generated via different protocols, PCLDA remains stable and often outperforms more complex machine-learning approaches. Furthermore, PCLDA offers strong interpretability, attributed to the linear nature of its PCA and LDA modules. The final decision boundaries are linear combinations of the original gene expression values, directly reflecting the contribution of each gene to the classification. Top-weighted genes identified by PCLDA better capture biologically meaningful signals in enrichment analyses than those selected via marginal screening alone, offering deeper functional insights into cell-type specificity. In conclusion, our work underscores the utility of carefully enhanced simple statistics methods for single-cell annotation. PCLDA's simplicity, interpretability, and consistently high performance make it a practical, reliable alternative to more complex annotation pipelines. Code is available on GitHub:https://github.com/kellen8hao/PCLDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.